Skip to main navigation

Main Menu

About
Our Approach
Pipeline
- Publications
Therapeutic Focus
Careers
- Current Openings
- Faces of Fulcrum
Investor Relations
Contact

News Releases

News Releases

Year

Aug 06, 2020

Fulcrum Therapeutics to Participate in Upcoming Investor Conferences

Aug 05, 2020

Fulcrum Therapeutics to Host Second Quarter 2020 Financial Results Conference Call and Webcast on Tuesday, August 11, 2020 at 8:00 a.m. ET

Jul 21, 2020

MyoKardia and Fulcrum Therapeutics Announce Multi-Target Collaboration to Discover Novel Targeted Therapies for Genetic Cardiomyopathies

Jun 24, 2020

Fulcrum Therapeutics Announces Initiation of Multi-Center Phase 3 (LOSVID) Trial with Losmapimod for Hospitalized COVID-19 Patients

Jun 10, 2020

Fulcrum Therapeutics Completes $68.5 Million Private Placement

Jun 10, 2020

Fulcrum Therapeutics to Evaluate Losmapimod as Potential Treatment for COVID-19

May 21, 2020

Fulcrum Therapeutics Announces Multiple Presentations at the 2020 American Academy of Neurology (AAN) Science Highlights Virtual Platform

May 13, 2020

Fulcrum Therapeutics Reports Recent Business Highlights and First Quarter 2020 Financial Results

May 11, 2020

Fulcrum Therapeutics to Present at the BofA Securities 2020 Health Care Conference

May 07, 2020

Fulcrum Therapeutics to Host First Quarter 2020 Financial Results Conference Call and Webcast on Wednesday, May 13, 2020 at 8:00 a.m. ET

Pagination

First page
Previous page
Page 1
Current page 2
Page 3
Next page
Last page

Displaying 11 - 20 of 30

Investor Tools

Privacy Policy
EU Privacy Policy
Terms of Use

Twitter
LinkedIn
Instagram

Main Menu

About
Our Approach
Pipeline
- Publications
Therapeutic Focus
Careers
- Current Openings
- Faces of Fulcrum
Investor Relations
Contact